First anthrax vaccine developed using recombinant DNA technology- Annual production capacity of up to 10 million doses at GC ...
Sino Bioking (Tianjin) Biological Pharmaceutical Co., Ltd., a tech firm incubated in Beijing's Zhongguancun, known as the country's Silicon Valley, recently announced a major milestone: its ...
Everon Healthcare is a distinguished Chinese company focused on the research, development and industrialization of recombinant triple-helical collagen.
Evry, December 11th 2025 - Eukar s, a Paris-based biotechnology company developing the world’s first multifunctional RNA polymerase to boost biomanufacturing yields in mammalian cells, today announced ...
All G's human lactoferrin will be bio-equivalent to the native form with greater than 95% purity. As the company's first recombinant human milk protein, it marks a step toward improving early life ...
All G is gearing up to launch its first product—recombinant bovine lactoferrin—in Q1 2026, says CEO Jan Pacas.
(GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and information, reports that Kraig Biocraft Laboratories (OTCQB: ...
Diabetes goes beyond just glucose control, and recent advancements in research are enhancing drug development for the disease.
Key market opportunities in the IVD Raw Materials sector include the expanding demand for high-purity materials due to ...
The protein, reverse transcriptase, has become an essential tool for making DNA copies of RNA.
Dyadic International, Inc. ( DYAI) IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 December 9, 2025 9:30 AM EST Good day, and welcome to the iAcessAlpha Virtual Best Ideas winter ...
The "IVD Raw Materials - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for IVD Raw Materials was valued at US$27.7 Billion in 2024 and is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results